Bibliography
- HURWITZ N: Predisposing factors in adverse reactions to drugs. Br. Med. 1 (1969) 1:536–539.
- •One of four references that are of significant historical importance in pharmacoepidemiology.
- LEVY M, KLETTER-HEMO D, NIR I, ELIAKIM M: Drug utilization and adverse drug reactions in medical patients: comparison of two periods, 1969-72 and 1973-76. Isc J. Med. Sci. (1977) 13:1065–1072.
- •One of four references that are of significant historical importance in pharmacoepidemiology.
- SEIDL LG, THORNTON GF, SMITH JW, CLUFF LE: Studies on the epidemiology of adverse drug reactions: reactions in patients on a general medical service. Bull. Johns Hopkins Hosp. (1966) 119:299–315.
- •One of four references that are of significant historical importance in pharmacoepidemiology.
- GREENBLATT DJ, ALLEN MD, SHADER RI: Toxicity of high dose flurazepam in the elderly. OM. Pharmacy] Ther. (1977) 21:355–361.
- •One of four references that are of significant historical importance in pharmacoepidemiology.
- LAZAROU J, POMERANZ BH, COREY PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA (1998) 279:1200–1205.
- TANNER LA, BAUM C: Spontaneous adverse reaction reporting in the elderly. Lancet (1988) 2:580.
- HOPF G, MATHIAS B: Adverse reactions reporting and age. Lancet (1988) 2:1079.
- MANN RD, RAWLINS MD, FLETCHER P, WOOD SM: Age and spontaneous reporting of adverse reactions in the United Kingdom. Phannacaepidernial. Drug Sal: (1992) 1:19–23.
- CARBONIN P, PAHOR M, BERNABEI R, SGADARI A: Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? 1. Am. Geriatr. Soc. (1991) 39:1093-1099. ccA useful study that addresses many of theissues described in this article.
- DICKINSON D, WILKIE P, HARRIS M: Taking medicines: concordance is not compliance. Br Med. J. (1999) 319:787.
- NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE: Guidance on the use of cyclooxygenase (COX) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis. Technology appraisal No. 27. 11 The Strand, London, WC2N 5HR, UK (2001).
- BOMBARDIER C, LAINE L, REICIN A et al.: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Eng] J. Med. (2000) 343:1520–1528.
- DALEN JE: Selective COX-2 inhibitors, NSAIDs, aspirin, and myocardial infarction. Arch. Intern. Med. (2002) 162:1091–1092.
- CAMPBELL AJ: Drug treatment as a cause of falls in old age. A review of the offending agents. Drugs Aging (1991)1:289–302.
- HERINGS RM, STRICKER BH, DE-BOER A, BAKKER A, STURMANS F: Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch. Intern. Med. (1995) 155:1801–1807.